- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Agfa and Mitra form joint venture
PACS developers Agfa of Mortsel, Belgium, and Mitra of Waterloo, Ontario, have formed a joint-venture company called Impax Technology to develop and sell PACS software based on Agfa’s Impax product line. The new company will be headed by Mitra chief
PACS developers Agfa of Mortsel, Belgium, and Mitra of Waterloo, Ontario, have formed a joint-venture company called Impax Technology to develop and sell PACS software based on Agfas Impax product line. The new company will be headed by Mitra chief executive Eric Peterson and will also sell Impax software to other companies.
Agfa has become the industrys leading PACS company thanks largely to the Impax software, which Mitra developed for Agfa. The companies have been in discussions for the last several months about restructuring their eight-year relationship. The joint-venture deal allows Agfa to maintain access to the Impax software while creating a new pool of potential OEM customers for Mitra. Impax Technology will be based in Waterloo.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
